Paul Lucas

Director at Ontario Genomics Institute (Private Equity)

Paul Lucas

Paul Lucas

Director at Ontario Genomics Institute (Private Equity)

Overview
Career Highlights

GlaxoSmithKline, Inc.

RelSci Relationships

282

Number of Boards

11

Birthday

1951

Age

67

Relationships

Founder at ABcann Global Corp.

Director & Co-Founder at Select Therapeutics, Inc.

President & Chief Executive Officer at RNA Diagnostics, Inc.

Chief Financial Officer at RNA Diagnostics, Inc.

Chief Executive Officer & Director at ABcann Global Corp.

Former Executive Vice President at EMD Serono, Inc.

Chief Executive Officer & Director at EcoSynthetix, Inc.

Honorary Professor at University of Western Ontario

Treasurer at American Society for Microbiology

Former Research Director Emeritus, Samuel Lunenfeld Research Institute at The Mount Sinai Hospital

Subscribe to RelSci Professional to see 282 more Relationships
In The News
News Bites Canadian Markets
February 20, 2018
EcoSynthetix decreases February 20, 2018 17:00 EST
News Bites Canadian Markets
February 13, 2018
EcoSynthetix increases 1.3% February 13, 2018 17:00 EST
News Bites Canadian Markets
February 5, 2018
EcoSynthetix decreases February 05, 2018 17:00 EST
News Bites Canadian Markets
January 30, 2018
EcoSynthetix sinks 4.2% January 30, 2018 17:00 EST
Subscribe now to see full news coverage
Paths to Paul Lucas
Potential Connections via
Relationship Science
You
Paul Lucas
Director at Ontario Genomics Institute (Private Equity)
Education

Queen's University at Kingston (commonly shortened to Queen's University or Queen's) is a public research university located in Kingston, Ontario, Canada. Founded on 16 October 1841, the university predated the founding of Canada by 26 years. Queen's holds more than 1,400 hectares (3,500 acres) of land throughout Ontario and owns Herstmonceux Castle in East Sussex, England. Queen's is organized into ten undergraduate, graduate and professional faculties and schools. The Church of Scotland established Queen's College in 1841 with a royal charter from Queen Victoria. The first classes, intended to prepare students for the ministry, were held 7 March 1842 with 13 students and two professors. Queen's was the first university west of the maritime provinces to admit women, and to form a student government. In 1883, a women's college for medical education affiliated with Queen's University. In 1888, Queen's University began offering extension courses, becoming the first Canadian university to do so. In 1912, Queen's secularized and changed to its present legal name.

Career History
Director
2009 - Current

Ontario Genomics Institute focuses on using world-class research to create strategic genomics resources and to accelerate Ontario's development of a globally-competitive life sciences sector. They strategically cultivate, fund and manage large-scale genomics projects and the genomics resources they create, as well as technology development and technology service platform provision associated with these projects. OGI aims to provide early-stage funding as companies (on their own or with academic collaborators) move towards commercial applications and to speed up transfer of products from lab to marketplace. The fund invests up to $100K per project. They tend to invest in the following sectors: Biofuels, Diagnostics, therapeutics, Crop or livestock trait improvements, Environmental management (related to water, mining, energy, other), Forestry, Laboratory and medical devices, Food, Informatics including databases, software, other tools.

President & Chief Executive Officer
1986 - 2012

GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada.

Professional
Prior

Eli Lilly Canada, Inc., part of Eli Lilly & Co., is a Canadian company located in Scarborough, ON, specializing in pharmaceutical preparations.

Subscribe now for extended career history
Boards & Committees
Chairman of the Board
2017 - Current

ABcann Global Corp. produces marijuana for medical purposes. The company focuses on curing diseases through medical cannabis. Its products include Si:med, Nc:med, Wp:med, Ic:med, Op:med, Sn:med and Dc:med. ABcann Global was founded by Ken Clement in 2007 and is headquartered in Napanee, Canada.

Chairman of the Board
2015 - Current

EcoSynthetix, Inc. focuses on commercializing a range of bio based polymer and monomer products. It offers engineered biopolymers that replace the non-renewable chemicals used to manufacture products, such as paper and packaging, personal care products, insulation and wood composites. The Company's products include, EcoSphere biolatex and DuraBindTM biopolymers, provide a sustainable alternative that reduces a customer's carbon footprint, decreases overall material costs and improves performance. EcoSynthetix was founded by John van Leeuwen and Steven Bloembergen in 1996 and is headquartered in Burlington, Canada.

Director
1998 - Current

Select Therapeutics, Inc. operates as a development stage biopharmaceutical company. It is focused on the development of cell based therapeutics production. The company was founded by Clifford A. Lingwood in January 1997 and is headquartered in Brookline, MA.

Subscribe now to see 6 more corporate board memberships
Chairman, Board of Directors
Prior - 2017
Subscribe now to see non-profit board memberships for over 7 million people
Subscribe now to see government board memberships for over 7 million people
Public Holdings
Restricted data only for RelSci Professional users.
Subscribe now to see public holdings for over 7 million people